- Home
- MPLX vs BDX Comparison
MPLX vs BDX Comparison
Compare MPLX & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPLX
- BDX
- Stock Information
- Founded
- MPLX 2012
- BDX 1897
- Country
- MPLX United States
- BDX United States
- Employees
- MPLX N/A
- BDX N/A
- Industry
- MPLX Oil & Gas Production
- BDX Medical/Dental Instruments
- Sector
- MPLX Energy
- BDX Health Care
- Exchange
- MPLX Nasdaq
- BDX Nasdaq
- Market Cap
- MPLX 54.7B
- BDX 58.9B
- IPO Year
- MPLX 2012
- BDX 1962
- Fundamental
- Price
- MPLX $51.02
- BDX $172.57
- Analyst Decision
- MPLX Buy
- BDX Buy
- Analyst Count
- MPLX 9
- BDX 9
- Target Price
- MPLX $54.33
- BDX $235.63
- AVG Volume (30 Days)
- MPLX 1.4M
- BDX 3.6M
- Earning Date
- MPLX 05-06-2025
- BDX 05-01-2025
- Dividend Yield
- MPLX 7.50%
- BDX 2.41%
- EPS Growth
- MPLX 11.58
- BDX 14.07
- EPS
- MPLX 4.33
- BDX 5.16
- Revenue
- MPLX $11,380,000,000.00
- BDX $20,867,000,000.00
- Revenue This Year
- MPLX $16.90
- BDX $9.28
- Revenue Next Year
- MPLX $4.73
- BDX $4.92
- P/E Ratio
- MPLX $11.78
- BDX $33.43
- Revenue Growth
- MPLX 5.46
- BDX 5.84
- 52 Week Low
- MPLX $39.95
- BDX $163.33
- 52 Week High
- MPLX $54.87
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- MPLX 51.08
- BDX 38.31
- Support Level
- MPLX $50.41
- BDX $169.60
- Resistance Level
- MPLX $51.55
- BDX $176.43
- Average True Range (ATR)
- MPLX 0.89
- BDX 3.46
- MACD
- MPLX 0.05
- BDX 1.54
- Stochastic Oscillator
- MPLX 63.11
- BDX 40.36
About MPLX MPLX LP
MPLX is a partnership that owns both pipelines and gathering and processing assets with extensive holdings in the Appalachian region. The asset base is made up of pipeline assets dropped down from Marathon Petroleum, its sponsor, and gathering and processing assets from MarkWest, which it acquired in 2015. MPLX also acquired Andeavor Logistics in 2019.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.